Michael Farber

Davis Polk is advising the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $90 million aggregate principal amount of…

Davis Polk advised the sole book-running manager in connection with the $172.5 million initial public offering of 17,250,000 units of Population Health Investment Co., Inc., which includes…

Davis Polk advised the underwriter in connection with a block trade of 9,180,569 shares of common stock of Intercontinental Exchange, Inc. by a selling shareholder. The shares sold in…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by NovoCure Limited of $575 million aggregate principal amount of its 0.000%…

Davis Polk advised the representative of the initial purchasers in connection with the debut Rule 144A/Regulation S offering by LD Holdings Group LLC of $500 million aggregate principal…

Davis Polk advised the representative of the initial purchasers in connection with concurrent Rule 144A/Regulation S offerings by Ligado Networks LLC of $2.85 billion aggregate principal…

Davis Polk advised the underwriters in connection with the $200 million initial public offering of 20,000,000 units of Decarbonization Plus Acquisition Corporation. Each unit consists…

Davis Polk advised  the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…

Davis Polk advised the joint book-running managers in connection with the $97.75 million initial public offering of 9,775,000 units of Turmeric Acquisition Corp., which includes 1,275…

Davis Polk advised Toyota Motor Credit Corporation in connection with an SEC-registered offering of $600 million aggregate principal amount of floating-rate medium-term notes, Series B due…